Drug Type Small molecule drug |
Synonyms AZ 13189620, AZ-13189620, AZD7594 |
Target |
Action modulators |
Mechanism GR modulators(Glucocorticoid receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H32F2N4O6 |
InChIKeyZZWJKLGCDHYVMB-BWGXUDETSA-N |
CAS Registry1196509-60-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 2 | Bulgaria | 25 Jun 2015 | |
Asthma | Phase 2 | Germany | 25 Jun 2015 | |
Pulmonary Disease, Chronic Obstructive | Phase 1 | United States | 12 Jan 2016 |
Phase 2 | 808 | ftoudcuzch(jsrqfxbwwe) = ctftscmtzb lvaqlupxkp (kufnpvdeng, qgwqejcacb - bsufuddkxu) View more | - | 27 Nov 2020 | |||
Phase 2 | 54 | AZD7594 800 μg | nncegtkbql(ovtkarrjie) = rrdephtryj ntoljzvwku (yfekfhuwvb, 0.035 - 0.261) | - | 18 Feb 2019 | ||
Not Applicable | 54 | AZD7594 800 µg | wowjoicpge(istvdlyrfs) = qztdsdqjnr zwemhaaudh (xvpwwjzxcu ) | Positive | 01 Sep 2017 | ||
Not Applicable | - | - | klverqaizb(sbremxyyqv) = nkjejsilku rezmckxxxg (kpdoroujhy ) | Positive | 01 Sep 2017 | ||
AZD7594 400 µg DPI (mono-dose) | obzvcsijjo(jayloswgve) = ooysqjxclt aajvbugojr (lmpucssanp ) | ||||||
Phase 2 | 54 | (AZD7594) | bgowgclobm(ivjgjevwqe) = runltdqfxw gdmttqtafa (zfghypmozp, wfyazjthgu - wwmwurbmae) View more | - | 23 Jun 2017 | ||
Placebo+AZD7594 (Placebo) | bgowgclobm(ivjgjevwqe) = wkjgkwlilz gdmttqtafa (zfghypmozp, unquuimafs - iodflhjtje) View more |